Baseline PET/CT Radiomics and Clinical Indicators for Pretreatment Response Prediction in Unresectable Hepatocellular Carcinoma: Model Development and Internal Validation.
IntroductionPretreatment prediction of benefit from targeted therapy plus immunotherapy remains uncertain in unresectable hepatocellular carcinoma (HCC). We developed and internally validated a model integrating baseline 18F-FDG PET/CT radiomics with clinical indicators.MethodsThis single-center retrospective study inc...